Nanjing Pharmaceutical Group Company LimitedSSE: 600713

Announcement on Implementing Cancellation of Repurchased Shares and Share Changes

Mar 24, 2026 · Issued by Nanjing Pharmaceutical Group Company Limited via Shanghai Stock Exchange

Filed with SSE · Mar 24, 2026

On 6ix: 6ix.com/news/announcement-on-implementing-cancellation-of-repurchased-shares-and-share-changes-5

Announcement on Implementing Cancellation of Repurchased Shares and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Nanjing Pharmaceutical Group Company Limited on 6ix

Earlier from Nanjing Pharmaceutical

Announcement on the Change of Project Quality Reviewer by Audit InstitutionMar 18
Announcement on Issuance Result of Phase IV Ultra-Short-Term Financing Bonds of 2026Mar 11
Announcement on Issuance Result of Phase III Ultra-Short-Term Financing Bonds of 2026Mar 10
Announcement on Progress in Use of Part of the Temporarily Idle Raised Proceeds for Cash Management by the Company and Its SubsidiariesMar 5
Announcement on Completion of Share Transfer by Shareholders Holding More than 5% of SharesFeb 28

Later from Nanjing Pharmaceutical

Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2026Mar 26
Announcement on Conversion Result of Convertible Bonds and Share ChangesApr 2
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026Apr 3
Announcement on Election of Employee Representative Directors for the 10th Board of DirectorsApr 8
Announcement on Progress in Government’s Expropriation of Certain Real Estate and Land of the Company’s Tier-II SubsidiaryApr 11

All Nanjing Pharmaceutical news releases

Follow Nanjing Pharmaceutical into a list and get an email when it puts out news.

Follow Nanjing Pharmaceutical